Dow Up 0.26% Nasdaq Up 0.15%

Novo Nordisk A/S (NVO)

-NYSE
47.74 Down 0.66(1.36%) 11:58AM EDT - NYSE Real Time Price
Prev Close:48.40
Open:47.70
Bid:47.80 x 1500
Ask:47.81 x 900
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:47.65 - 48.00
52wk Range:32.55 - 49.11
Volume:396,430
Avg Vol (3m):964,875
Market Cap:125.50B
P/E (ttm):28.59
EPS (ttm):1.67
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVODown 1.36%125.50B
LLYDown 0.21%69.87B
PFEUp 0.37%189.46B
SNYUp 1.67%148.64B

Key Statistics

Forward P/E (1 yr):23.91
P/S (ttm):8.82
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.78
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback